Literature DB >> 19806642

Membranous labyrinth volumes in normal ears and Ménière disease: a three-dimensional reconstruction study.

Norimasa Morita1, Shin Kariya, Armin Farajzadeh Deroee, Sebahattin Cureoglu, Shigenobu Nomiya, Rie Nomiya, Tamotsu Harada, Michael M Paparella.   

Abstract

OBJECTIVES: The purpose of this study was to determine the normal volume ranges of cochlear duct, saccule, and utricle, and to assess endolymphatic hydrops in Ménière disease. STUDY
DESIGN: Retrospective temporal bone study.
METHODS: Three-dimensional (3-D) images of membranous labyrinth were reconstructed from 31 normal temporal bones, six temporal bones from three patients with bilateral Ménière disease, and 16 temporal bones from eight patients with unilateral Ménière disease. Volumes of each part of membranous labyrinth were measured in each temporal bone group after 3-D reconstruction.
RESULTS: The mean volumes and upper normal volume limits (over the 95% confidence interval) of the cochlear duct, saccule, and utricle were 7.67 and 9.77 mm(3), 2.42 and 3.68 mm(3), and 10.65 and 16.45 mm(3), respectively. All three patients with bilateral Ménière disease showed endolymphatic hydrops (excess of volume over normal limits) in both ears. Of eight patients with unilateral Ménière disease, five had no symptom in the contralateral ear, whereas three patients had histories of progression from unilateral to bilateral Ménière disease 13-21 years after the initial onset. All of the diseased and three of eight contralateral ears showed endolymphatic hydrops. In contrast, no hydrops was observed in any part of the membranous labyrinth in asymptomatic ears.
CONCLUSIONS: Our findings suggest that cochleosaccular hydrops is a sensitive finding in Ménière disease. In addition, the volume data obtained from this study could be useful as a standard value for the assessment of hydrops in diagnostic imaging of the inner ear in Ménière disease.

Entities:  

Mesh:

Year:  2009        PMID: 19806642      PMCID: PMC2927481          DOI: 10.1002/lary.20723

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  14 in total

1.  T2-weighted turbo spin-echo images, maximum-intensity projections, and three-dimensional volume-rendering for delineation of pathologies and anatomic details of the inner ear.

Authors:  Gabriele A Krombach; Sandra Martiny; Ercole Di Martino; Michael Westhofen; Sven Stanzel; Patrick Haage; Andreas Prescher; Arno Buecker; Rolf W Günther
Journal:  Invest Radiol       Date:  2004-12       Impact factor: 6.016

Review 2.  Endolymphatic sac revision for recurrent intractable Meniere's disease.

Authors:  Michael M Paparella
Journal:  Otolaryngol Clin North Am       Date:  2006-08       Impact factor: 3.346

3.  Vestibular evoked myogenic potentials (VEMP) can detect asymptomatic saccular hydrops.

Authors:  Ming-Yee Lin; Ferdinand C A Timmer; Brad S Oriel; Guangwei Zhou; John J Guinan; Sharon G Kujawa; Barbara S Herrmann; Saumil N Merchant; Steven D Rauch
Journal:  Laryngoscope       Date:  2006-06       Impact factor: 3.325

4.  Visualization of endolymphatic hydrops in patients with Meniere's disease.

Authors:  Tsutomu Nakashima; Shinji Naganawa; Makoto Sugiura; Masaaki Teranishi; Michihiko Sone; Hideo Hayashi; Seiichi Nakata; Naomi Katayama; Ieda Maria Ishida
Journal:  Laryngoscope       Date:  2007-03       Impact factor: 3.325

5.  Volume of components of labyrinth: magnetic resonance imaging study.

Authors:  Tuba Karagulle Kendi; Osman Kursat Arikan; Can Koc
Journal:  Otol Neurotol       Date:  2005-07       Impact factor: 2.311

6.  Meniere's syndrome and endolymphatic hydrops. Double-blind temporal bone study.

Authors:  S D Rauch; S N Merchant; B A Thedinger
Journal:  Ann Otol Rhinol Laryngol       Date:  1989-11       Impact factor: 1.547

7.  Utricular and saccular volumetry in human temporal bones.

Authors:  M Igarashi; T O-Uchi; H Isago; W K Wright
Journal:  Acta Otolaryngol       Date:  1983 Jan-Feb       Impact factor: 1.494

8.  Cellular changes of Reissner's membrane in Meniere's disease: human temporal bone study.

Authors:  Sebahattin Cureoglu; Patricia A Schachern; Saurav Paul; Michael M Paparella; Rajesh K Singh
Journal:  Otolaryngol Head Neck Surg       Date:  2004-01       Impact factor: 3.497

9.  3 Tesla delayed contrast magnetic resonance imaging evaluation of Ménière's disease.

Authors:  Matthew J Carfrae; Adrian Holtzman; Fred Eames; Steven M Parnes; Allison Lupinetti
Journal:  Laryngoscope       Date:  2008-03       Impact factor: 3.325

10.  Histopathologic changes of contralateral human temporal bone in unilateral Ménière's disease.

Authors:  Shin Kariya; Sebahattin Cureoglu; Hisaki Fukushima; Takeshi Kusunoki; Patricia A Schachern; Kazunori Nishizaki; Michael M Paparella
Journal:  Otol Neurotol       Date:  2007-12       Impact factor: 2.311

View more
  19 in total

1.  A probabilistic atlas of the human inner ear's bony labyrinth enables reliable atlas-based segmentation of the total fluid space.

Authors:  Valerie Kirsch; F Nejatbakhshesfahani; S-A Ahmadi; M Dieterich; B Ertl-Wagner
Journal:  J Neurol       Date:  2019-08-17       Impact factor: 4.849

2.  MRI of endolymphatic hydrops in patients with Meniere's disease: a case-controlled study with a simplified classification based on saccular morphology.

Authors:  Arnaud Attyé; Michael Eliezer; Naïla Boudiaf; Irène Tropres; David Chechin; Sébastien Schmerber; Georges Dumas; Alexandre Krainik
Journal:  Eur Radiol       Date:  2016-12-20       Impact factor: 5.315

3.  Recurrent peripheral vestibulopathy: Is MRI useful for the diagnosis of endolymphatic hydrops in clinical practice?

Authors:  Arnaud Attyé; G Dumas; I Troprès; M Roustit; A Karkas; E Banciu; J Pietras; L Lamalle; S Schmerber; A Krainik
Journal:  Eur Radiol       Date:  2015-03-28       Impact factor: 5.315

4.  Evaluation of endolymphatic hydrops using 3-T MRI after intravenous gadolinium injection.

Authors:  Takao Imai; Atsuhiko Uno; Tadashi Kitahara; Tomoko Okumura; Arata Horii; Yumi Ohta; Takashi Sato; Suzuyo Okazaki; Takefumi Kamakura; Yoshiyuki Ozono; Yoshiyuki Watanabe; Yukiko Hanada; Ryusuke Imai; Kazuya Ohata; Hidenori Inohara
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-25       Impact factor: 2.503

Review 5.  Is allergy related to Meniere's disease?

Authors:  Catherine Banks; Samuel McGinness; Richard Harvey; Raymond Sacks
Journal:  Curr Allergy Asthma Rep       Date:  2012-06       Impact factor: 4.806

6.  In vivo imaging of saccular hydrops in humans reflects sensorineural hearing loss rather than Meniere's disease symptoms.

Authors:  Arnaud Attyé; Michael Eliezer; Maud Medici; Irène Tropres; Georges Dumas; Alexandre Krainik; Sébastien Schmerber
Journal:  Eur Radiol       Date:  2018-03-21       Impact factor: 5.315

7.  Visualization of the saccule and utricle with non-contrast-enhanced FLAIR sequences.

Authors:  Hikaru Fukutomi; Lydia Hamitouche; Takayuki Yamamoto; Laurent Denat; Lijun Zhang; Bei Zhang; Valentin Prevost; Bruno Triaire; Vincent Dousset; Xavier Barreau; Thomas Tourdias
Journal:  Eur Radiol       Date:  2021-12-20       Impact factor: 5.315

8.  Detailed insight into magnetic resonance assessment of Ménière's disease - description of methodology and imaging findings in a case series.

Authors:  Emilia Wnuk; Magdalena Lachowska; Agnieszka Jasińska-Nowacka; Edyta Maj; Olgierd Rowiński; Kazimierz Niemczyk
Journal:  Pol J Radiol       Date:  2022-06-30

9.  Correlation of semi-quantitative findings of endolymphatic hydrops in MRI with the audiometric findings in patients with Meniere's disease.

Authors:  Mohammad Ali Kazemi; Ali Ghasemi; Jan W Casselman; Mohammad Shafiei; Masoud Motasaddi Zarandy; Hashem Sharifian; Hassan Hashemi; Kavous Firouznia; Behnaz Moradi; Kianosh Kasani; Azin Etemadimanesh
Journal:  J Otol       Date:  2022-04-16

10.  Association between hearing loss and saccular dysfunction in older individuals.

Authors:  Maria Geraldine Zuniga; Roni E Dinkes; Marcela Davalos-Bichara; John P Carey; Michael C Schubert; W Michael King; Jeremy Walston; Yuri Agrawal
Journal:  Otol Neurotol       Date:  2012-12       Impact factor: 2.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.